Go Pro
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel Free PYC Stock Alerts

Physiomics (PYC) Competitors

Physiomics logo
GBX 0.50 +0.01 (+2.05%)
As of 11:36 AM Eastern
Compare

PYC vs. SNG, BVX, OBD, OPTI, and TLM

Should you buy Physiomics stock or one of its competitors? MarketBeat compares Physiomics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Physiomics include Synairgen (SNG), BiVictriX Therapeutics (BVX), Oxford BioDynamics (OBD), OptiBiotix Health (OPTI), and Talisman Metals (TLM). These companies are all part of the "biotechnology" industry.

How does Physiomics compare to Synairgen?

Synairgen (LON:SNG) and Physiomics (LON:PYC) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.

30.7% of Synairgen shares are held by institutional investors. Comparatively, 0.8% of Physiomics shares are held by institutional investors. 3.2% of Synairgen shares are held by insiders. Comparatively, 3.3% of Physiomics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Physiomics has higher revenue and earnings than Synairgen. Physiomics is trading at a lower price-to-earnings ratio than Synairgen, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SynairgenN/AN/A-£15.86M-£1.66N/A
Physiomics£953.01K2.37-£922.82K-£0.15N/A

In the previous week, Synairgen's average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.

Company Overall Sentiment
Synairgen Neutral
Physiomics Neutral

Synairgen has a beta of -2.23, indicating that its stock price is 323% less volatile than the broader market. Comparatively, Physiomics has a beta of 1.025, indicating that its stock price is 2% more volatile than the broader market.

Synairgen has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Synairgen's return on equity of -51.06% beat Physiomics' return on equity.

Company Net Margins Return on Equity Return on Assets
SynairgenN/A -51.06% -30.58%
Physiomics -50.92%-89.43%-76.38%

Summary

Synairgen and Physiomics tied by winning 5 of the 10 factors compared between the two stocks.

How does Physiomics compare to BiVictriX Therapeutics?

BiVictriX Therapeutics (LON:BVX) and Physiomics (LON:PYC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability, valuation and media sentiment.

BiVictriX Therapeutics has a beta of -0.73, meaning that its stock price is 173% less volatile than the broader market. Comparatively, Physiomics has a beta of 1.025, meaning that its stock price is 2% more volatile than the broader market.

In the previous week, BiVictriX Therapeutics' average media sentiment score of 0.00 equaled Physiomics'average media sentiment score.

Company Overall Sentiment
BiVictriX Therapeutics Neutral
Physiomics Neutral

Physiomics has higher revenue and earnings than BiVictriX Therapeutics. Physiomics is trading at a lower price-to-earnings ratio than BiVictriX Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BiVictriX TherapeuticsN/AN/A-£2.67M-£0.04N/A
Physiomics£953.01K2.37-£922.82K-£0.15N/A

30.8% of BiVictriX Therapeutics shares are owned by institutional investors. Comparatively, 0.8% of Physiomics shares are owned by institutional investors. 42.6% of BiVictriX Therapeutics shares are owned by insiders. Comparatively, 3.3% of Physiomics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

BiVictriX Therapeutics has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Physiomics' return on equity of -89.43% beat BiVictriX Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
BiVictriX TherapeuticsN/A -103.99% -62.99%
Physiomics -50.92%-89.43%-76.38%

Summary

BiVictriX Therapeutics and Physiomics tied by winning 5 of the 10 factors compared between the two stocks.

How does Physiomics compare to Oxford BioDynamics?

Physiomics (LON:PYC) and Oxford BioDynamics (LON:OBD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk.

Physiomics has a net margin of -50.92% compared to Oxford BioDynamics' net margin of -1,018.54%. Physiomics' return on equity of -89.43% beat Oxford BioDynamics' return on equity.

Company Net Margins Return on Equity Return on Assets
Physiomics-50.92% -89.43% -76.38%
Oxford BioDynamics -1,018.54%-316.67%-56.23%

Physiomics has a beta of 1.025, suggesting that its share price is 2% more volatile than the broader market. Comparatively, Oxford BioDynamics has a beta of 0.42, suggesting that its share price is 58% less volatile than the broader market.

In the previous week, Oxford BioDynamics had 1 more articles in the media than Physiomics. MarketBeat recorded 1 mentions for Oxford BioDynamics and 0 mentions for Physiomics. Physiomics' average media sentiment score of 0.00 equaled Oxford BioDynamics'average media sentiment score.

Company Overall Sentiment
Physiomics Neutral
Oxford BioDynamics Neutral

0.8% of Physiomics shares are owned by institutional investors. Comparatively, 25.4% of Oxford BioDynamics shares are owned by institutional investors. 3.3% of Physiomics shares are owned by insiders. Comparatively, 15.6% of Oxford BioDynamics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Physiomics has higher earnings, but lower revenue than Oxford BioDynamics. Physiomics is trading at a lower price-to-earnings ratio than Oxford BioDynamics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Physiomics£953.01K2.37-£922.82K-£0.15N/A
Oxford BioDynamics£1.10M5.53-£103.52M-£0.80N/A

Summary

Oxford BioDynamics beats Physiomics on 7 of the 12 factors compared between the two stocks.

How does Physiomics compare to OptiBiotix Health?

Physiomics (LON:PYC) and OptiBiotix Health (LON:OPTI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment and risk.

In the previous week, Physiomics' average media sentiment score of 0.00 equaled OptiBiotix Health'saverage media sentiment score.

Company Overall Sentiment
Physiomics Neutral
OptiBiotix Health Neutral

Physiomics has higher earnings, but lower revenue than OptiBiotix Health. Physiomics is trading at a lower price-to-earnings ratio than OptiBiotix Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Physiomics£953.01K2.37-£922.82K-£0.15N/A
OptiBiotix Health£1.17M5.75-£3.09M-£3.84N/A

Physiomics has a beta of 1.025, indicating that its stock price is 2% more volatile than the broader market. Comparatively, OptiBiotix Health has a beta of 1.85, indicating that its stock price is 85% more volatile than the broader market.

Physiomics has a net margin of -50.92% compared to OptiBiotix Health's net margin of -333.62%. OptiBiotix Health's return on equity of -52.92% beat Physiomics' return on equity.

Company Net Margins Return on Equity Return on Assets
Physiomics-50.92% -89.43% -76.38%
OptiBiotix Health -333.62%-52.92%-13.93%

0.8% of Physiomics shares are held by institutional investors. Comparatively, 0.4% of OptiBiotix Health shares are held by institutional investors. 3.3% of Physiomics shares are held by company insiders. Comparatively, 26.8% of OptiBiotix Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

OptiBiotix Health beats Physiomics on 7 of the 11 factors compared between the two stocks.

How does Physiomics compare to Talisman Metals?

Physiomics (LON:PYC) and Talisman Metals (LON:TLM) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Physiomics has higher revenue and earnings than Talisman Metals. Talisman Metals is trading at a lower price-to-earnings ratio than Physiomics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Physiomics£953.01K2.37-£922.82K-£0.15N/A
Talisman MetalsN/AN/A-£1.35M-£1.32N/A

In the previous week, Physiomics' average media sentiment score of 0.00 equaled Talisman Metals'average media sentiment score.

Company Overall Sentiment
Physiomics Neutral
Talisman Metals Neutral

0.8% of Physiomics shares are owned by institutional investors. Comparatively, 1.4% of Talisman Metals shares are owned by institutional investors. 3.3% of Physiomics shares are owned by company insiders. Comparatively, 95.2% of Talisman Metals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Talisman Metals has a net margin of 0.00% compared to Physiomics' net margin of -50.92%. Talisman Metals' return on equity of -32.71% beat Physiomics' return on equity.

Company Net Margins Return on Equity Return on Assets
Physiomics-50.92% -89.43% -76.38%
Talisman Metals N/A -32.71%3.70%

Physiomics has a beta of 1.025, suggesting that its share price is 2% more volatile than the broader market. Comparatively, Talisman Metals has a beta of 0.9, suggesting that its share price is 10% less volatile than the broader market.

Summary

Physiomics and Talisman Metals tied by winning 5 of the 10 factors compared between the two stocks.

Get Physiomics News Delivered to You Automatically

Sign up to receive the latest news and ratings for PYC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PYC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PYC vs. The Competition

Export
MetricPhysiomicsBiotechnology IndustryMedical SectorLON Exchange
Market Cap£2.26M£508.45M£6.85B£2.78B
Dividend Yield6.20%3.87%2.66%6.14%
P/E Ratio-3.323.1126.04366.54
Price / Sales2.376,785.72550.3985,951.69
Price / Cash4.2113.1329.0927.87
Price / Book2.3989.3710.987.75
Net Income-£922.82K-£96.07M£3.57B£5.89B
7 Day Performance-6.57%1.23%3.06%-1.01%
1 Month Performance-26.76%-0.19%0.72%-1.74%
1 Year Performance10.18%74.49%36.82%65.54%

Physiomics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PYC
Physiomics
N/AGBX 0.50
+2.0%		N/A+8.0%£2.26M£953.01KN/A10
SNG
Synairgen
N/AN/AN/AN/A£9.04MN/AN/A34
BVX
BiVictriX Therapeutics
N/AN/AN/AN/A£8.25MN/AN/A17
OBD
Oxford BioDynamics
N/AGBX 0.15
-7.3%		N/A-62.7%£6.57M£1.10MN/A45
OPTI
OptiBiotix Health
N/AGBX 6.15
+0.8%		N/A-42.6%£6.35M£1.17MN/A1

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:PYC) was last updated on 6/29/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
SpaceX is offering you shares. Don't take them.
SpaceX is reserving 30% of its IPO shares for retail investors through Robinhood, Fidelity, and Schwab. At a $...
Behind the Markets | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
Better than SpaceX? Grab this ticker instead.
Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...
Brownstone Research | Sponsoredtc pixel